working group NUMBER sensitivity organic gene polymorphisms convened review current understanding effects inhaled organic dust modified genetic increase reduce susceptibility furthermore group asked suggest areas require investigation field discussion focused individual sensitivity inhaled agents important determinant heterogeneiety responses exposures genetic modifiers known number pathologic conditions including asthma atopy chronic obstructive pulmonary disease hypersensitivity pneumonitis associated inhalation organic dusts modifiers likely identified number disease states studies required delineate precisely contribution role inflammatory cascade modulation known polymorphisms identify novel genetic factors dusts atopy factors inter individual